Completed

Limit: 1 // Tickets Available: 0

O. Miller (Museum of Art) 

The American Art Program supports scholarly loan exhibitions that contribute significantly to the study and understanding of art of the United States, including all facets of Native American art. These grants advance the Program’s efforts to empower art museums to reconsider accepted histories, amplify the voices and experiences of underrepresented artists and cultures, and facilitate important dialogue with diverse collaborators and communities.

Program Requirements and Guidelines

• Concept Notes must be submitted online by the originating institution and not by a participating-venue institution. (Letters are not accepted from individuals.)
• Art of the United States, including Native American art, should constitute significantly more than half of the checklist.
• The organizing institution’s permanent collection should not constitute more than half of the exhibition checklist.
• A single, privately held collection should constitute no more than half of the exhibition checklist.
• The holdings of a single commercial dealer should constitute no more than half of the exhibition checklist.
• The proposed exhibition should not open before March of the year following your application submission.
• Museums outside of the United States may submit appropriate projects for consideration only if they have proof of valid non-profit status provided by the U.S. Internal Revenue Service.
• Only one exhibition per year can be submitted per institution.

No Applicants // Limit: 2 (1 Translational nominee, 1 All-Star Translational nominee) // Tickets Available: 2 

The University of Arizona Cancer Center (UACC) can nominate up to two proposals: one Translational nominee and one All-Star Translational nominee (if eligible) for the V Foundation Adult Translational Cancer Research Award 2025. 

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the Translational Adult Cancer Research Grant which advances basic laboratory discoveries towards clinical use, ultimately improving human health and is restricted to adult cancer research.

This Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Limit: 1 per SIP

K. Ellingson (Public Health) for SIP25-005 Understanding the potential of early childcare and education (ECE) centers in promoting childhood vaccines and RSV prevention products

S. Carvajal (College of Public Health's Prevention Research Center) for SIP25-006 Overdose Prevention and Treatment Research Network (OPTRN)

Eligibility: 
Only one application per SIP per institution is allowed (e.g., multiple applications for the same SIP (listed in Section VIII) from the same institution are NOT permitted).

Purpose:
This Notice of Funding Opportunity (NOFO) invites applications from CDC Health Promotion and Disease Prevention Research Centers (PRCs), selected for funding under RFA-DP-24-004, to apply for supplemental funding to conduct Special Interest Research Projects (SIPs) to inform public health practice. PRCs will conduct high-quality applied health promotion and disease prevention research projects in real-world settings to identify, design, test, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) to prevent and reduce risk for the leading causes of illness, disability, and death in the United States.

Request Ticket // Limit: 4* (1 per grant type) // Tickets Available: 2

Legacy Researcher Grant // Limit 1 // Tickets Available: 1

Translational Research Grant // Limit: 1 // Tickets Available: 0
K. Huntoon (Neurosurgery) 

Emerging Investigator Fellowship Grant // Limit: 1 // Tickets Available: 0
S. Ganesh (Biomedical Engineering) 

Donor Designated Grant Program // Limit: 1 // Tickets Available: 1

Eligibility
Provide the name of the Institution, Principal Investigator and their title. An institution may only submit one LOI per award type. Multiple LOIs should not be submitted by the same researcher. 

Grant Categories 
The Pediatric Cancer Research Foundation awards four types of research grants: 

1. Legacy Researcher Grant (up to $100,000 per year, up to 2 years for translational research and up to $150,000 per year, for three years, for basic science research) 
   This grant is given to a long-standing PCRF-funded researcher for at least five years, who has demonstrated consistent progress and outcomes in pediatric cancer research. This funding category aims to support and sustain ongoing initiatives, ensuring that momentum is maintained on critical projects with potential for cures.  
2. Translational Research Grants (up to $100,000 per year, up to 2 years)  
   This grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. These grants support “bench to bedside” research, whose endpoint is often the planning or initiation of a clinical trial. 
3. Emerging Investigator Fellowship Grants (up to $75,000 for one year) 
   These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future. 
4. Donor Designated Grant Programs 
   These grants fund projects in communities or regions local to the specific donor or fundraising activity. Outside contributing organizations, fundraisers and donors work with the Foundation to identify a specific project and/or specific doctor, focus on a specific disease type, facility or awareness program. Grants can be for any specific amount as designated by the donor or contributing organization. PCRF will not accept grant application without an approved Letter of Intent (LOI). Please refer to the guidelines contained in this document for the specific guidelines. 
    

Limit: 1 // Tickets Available: 0
Q. Hao (Aerospace & Mechanical Engineering) 

Eligibility 
One (1) per organization as lead institution.

The scientific focus of the MIP program is subject to change from competition to competition. Information about the existing MIPs, from two previous competitions in 2015 and 2019, can be found at mip.org. The third MIP competition, in 2025, will accept proposals on alloys, amorphous, and composite materials. Given that the second MIP competition included an emphasis on biomaterials and polymer research, proposals mainly on these topics will not be considered in the third MIP competition.

Limit: 1 // Tickets Available: 0 

E. Gumm (Psychiatry - COM-T)

Application Limits
You may not submit more than one application. If you submit more than one
application, we will only accept the last on-time submission.|

If an entity applies as part of a consortium, the entity is not eligible to submit a
separate, stand-alone application.

Purpose
The purpose of the Addiction Medicine Fellowship (AMF) program is to expand the
number of fellows at accredited AMF and Addiction Psychiatry Fellowship (APF)
programs trained as addiction medicine specialists who practice in medically
underserved, community-based settings that integrate primary care with mental health
disorder and substance use disorder (SUD) prevention and treatment services. The
fellowship must include training in prevention and treatment services in medically
underserved, community-based settings, including in rural areas, that do not have
access or have limited access to SUD treatment. The program includes training for both
addiction medicine and/or addiction psychiatry fellows. Its goal is to increase the
number of physicians who are board-certified specialists in addiction medicine or
addiction psychiatry who will serve in medically underserved community-based
settings, including in rural areas, once trained. The program supports training to:
 

• Increase the number of fellows trained to practice addiction medicine and
  addiction psychiatry in rural and other medically underserved community-based
  settings.
• Establish partnerships with clinical rotation sites in rural or other underserved
  areas, that focus on the integration of primary care with mental health and SUD
  prevention and treatment services.
• Increase fellows’ knowledge and ability to assist their patients with referrals to
  navigate the legal and social systems related to patients’ clinical or care needs.
• Increase awareness of the specialty and reduce provider stigma to increase the
  number of physicians interested in pursuing careers in addiction medicine and
  addiction psychiatry through the provision of clinical rotations that expose
  medical residents to practice in these specialties and through education and
  consultation.

Limit: 1 // Tickets Available: 0

M.M. Kaelberer (Physiology) 

The current grant level is $300,000; $75,000 per year for a four-year period. For the 2026 award, one nomination will be invited from each of the participating institutions listed at the bottom of this page.

Eligibility

• Candidates must meet all of the following eligibility requirements:
• Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
• As of Sept. 3, 2025, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
  • Current appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible to apply.
• Must not have been appointed as an assistant professor and run an independent lab at any institution prior to June 11, 2021, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. This extension will end after this upcoming application cycle. Beginning next year, the eligibility window for the 2027 grant will revert to the three-year period. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2026 online application.
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Ideas with the potential to produce an unusually high impact are encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew scholars program. If you have questions concerning eligibility, please contact Pew Biomedical Programs (scholarsapp@pewtrusts.org) in advance of applying.

Funding Terms

An award of $75,000 per year for four years will be provided to the sponsoring institution for use by the scholar, subject to annual review of the scholar’s progress. Grant agreements will be issued in August of the award year. The awarded funds may be used at the discretion of the Pew scholar, for personnel, equipment, supplies, or travel directly related to the scholar's research and as to best advance his or her research and career.

• The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
• Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
• Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
• Subawards are allowed.

Limit: 2 // Available: 0

The Breast Cancer Alliance will accept a maximum of two LOIs per institution (Exceptional Projects Grant OR Young Investigators Grant)

Exceptional Projects Grant 
K. Fischer (Gurtner Laboratory - COM-T)
C. Lim (Public Health) 

Young Investigators Grant

YOUNG INVESTIGATORS GRANT
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant.  

This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support, but who design and conduct their own independent research projects. 

The term of the Young Investigator Grant is two years, beginning on March 1, 2026. The grant provides salary support and project costs for a total of a $125,000, distributed over a two-year period. 

Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs. 

Researchers should coordinate with their institutions, as BCA will accept a maximum of ONLY TWO LOIs PER INSTITUTION (YIG or XP.)

Qualifications 

Applicants for the 2026 award:

• Must not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2026
• Must not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2026
• Must dedicate at least 50% of their work effort to research
• Must be at an institution located in the contiguous United States.  
• Must not be a for-profit institution. 

EXCEPTIONAL PROJECTS GRANT 

Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant.  

This award recognizes creative, unique and innovative research related to breast cancer. 

The term of the Exceptional Project Grant is one year, beginning on March 1,2026. The grant provides salary support and project costs for a total of $100,000, distributed over a one-year period.  

Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs. 

Researchers should coordinate with their institutions, as BCA will accept a maximum of ONLY TWO LOIs PER INSTITUTION (YIG or XP).

Qualifications 

• This grant is open to applicants at institutions in the contiguous United States. 
• No for-profit institutions may apply.  

Limit: 2 // Tickets Available: 0

B. Yang (Architecture, Planning & Landscape Architecture) 
A. Zuniga (Geography, Development & Environment) 

The Thriving Communities Grantmaker Program, funded by the Inflation Reduction Act, signifies a crucial step towards advancing climate and environmental priorities. Our approach involves a strategic alliance of experienced community-based grant-makers with extensive networks in the region. By leveraging the collective expertise of our partners, including SEE’s proficiency in managing government grants and contracts, we seek to streamline the distribution process and maximize the impact of environmental justice initiatives.

Eligibility
Under this NOFO, Lead Applicants may submit a maximum of two applications. There is no limit on the amount of applications an organization can be a sub recipient on. 

Applications are accepted on a rolling basis.

RFA Withdrawn // Limit: 1 // Tickets Available: 1 

Duplicate or Multiple Submissions – submission of duplicate or predominantly overlapping applications is not allowed. NIFA will disqualify both applications if an applicant submits multiple applications that are duplicative or substantially overlapping to NIFA programs within the same RFA fiscal year. 

The National Institute of Food and Agriculture’s Agricultural Genome to Phenome Initiative (AG2PI), Assistance Listing 10.332, is intended to:  
1. Study agriculturally significant crops and animals in production environments to achieve sustainable and secure agricultural production. 
2. Ensure that current gaps in existing knowledge of agricultural crop and animal genetics and phenomics are filled. 
3. Identify and develop a functional understanding of relevant genes from animals and agronomically relevant genes from crops that are of importance to the agriculture sector of the United States. 
4. Ensure future genetic improvement of crops and animals of importance to the agriculture sector of the United States. 
5. Study the relevance of diverse germplasm as a source of unique genes that may be of importance in the future. 
6. Enhance genetics to reduce the economic impact of pathogens on crops and animals of importance to the agriculture sector of the United States. 
7. Disseminate findings to relevant audiences.